Pulse Biosciences (PLSE) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PLSE Stock Alerts $13.32 +1.95 (+17.15%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 3:44 PM | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Up 6.8%Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 6.8%May 25, 2024 | finance.yahoo.comPresident & CEO of Pulse Biosciences Burke Barrett Buys More StockMay 25, 2024 | americanbankingnews.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Acquires $85,600.00 in StockMay 24, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $11.95Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $11.95May 23, 2024 | insidertrades.comBurke Thomas Barrett Buys 10,000 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) StockMay 22, 2024 | marketbeat.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Buys 10,000 Shares of StockPulse Biosciences, Inc. (NASDAQ:PLSE - Get Free Report) CEO Burke Thomas Barrett bought 10,000 shares of the company's stock in a transaction on Monday, May 20th. The shares were bought at an average price of $8.56 per share, for a total transaction of $85,600.00. Following the transaction, the chief executive officer now owns 10,000 shares of the company's stock, valued at $85,600. The transaction was disclosed in a legal filing with the SEC, which is available at this link.May 22, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Sees Strong Trading VolumePulse Biosciences (NASDAQ:PLSE) Sees Large Volume IncreaseMay 21, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Up 8.2%Pulse Biosciences (NASDAQ:PLSE) Trading Up 8.2%May 20, 2024 | businesswire.comPulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000May 16, 2024 | seekingalpha.comPulse Biosciences Stock: Signs Of Life Following Q1 UpdateMay 16, 2024 | finance.yahoo.comPulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 16, 2024 | businesswire.comPulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 14, 2024 | finance.yahoo.comPulse Biosciences Enhances Executive Leadership TeamMay 13, 2024 | finance.yahoo.comPulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call TranscriptMay 12, 2024 | uk.investing.comEarnings call: Pulse Biosciences reports progress with CellFX systemMay 11, 2024 | finance.yahoo.comPulse Biosciences Insiders Added US$9.69m Of Stock To Their HoldingsMay 9, 2024 | finance.yahoo.comPulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemMay 8, 2024 | finance.yahoo.comPulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 7, 2024 | investorplace.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q1 2024May 7, 2024 | finance.yahoo.comPulse Biosciences Reports Q1 2024 Financial Results Amidst Strategic Business DevelopmentsMay 7, 2024 | businesswire.comPulse Biosciences Reports Business Updates and First Quarter 2024 Financial ResultsMay 2, 2024 | businesswire.comPulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000April 28, 2024 | insidermonkey.com5 ChatGPT Penny Stock Picks Right NowApril 24, 2024 | businesswire.comPulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024March 29, 2024 | finance.yahoo.comQ4 2023 Pulse Biosciences Inc Earnings CallMarch 28, 2024 | investorplace.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023March 28, 2024 | finance.yahoo.comPulse Biosciences Inc (PLSE) Reports Increased GAAP Costs and Narrowed Net Loss in 2023March 28, 2024 | businesswire.comPulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial ResultsMarch 28, 2024 | businesswire.comPulse Biosciences Announces Plans to Initiate a Rights OfferingMarch 19, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Stock Price Down 4.7%Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 4.7%March 17, 2024 | finance.yahoo.comPLSE Apr 2024 25.000 callMarch 17, 2024 | finance.yahoo.comPLSE Oct 2024 17.500 callMarch 16, 2024 | finance.yahoo.comPLSE Oct 2024 12.500 callMarch 16, 2024 | finance.yahoo.comPLSE Jul 2024 2.500 putMarch 14, 2024 | businesswire.comPulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024March 13, 2024 | msn.comPulse Biosciences’s CellFXnsPFA system secures FDA 510(k) clearanceMarch 10, 2024 | investing.comFDA clears Pulse Biosciences' soft tissue ablation systemMarch 9, 2024 | markets.businessinsider.comPulse Biosciences Gets FDA 510(k) Clearance For CellFX NsPFA Percutaneous Electrode SystemMarch 8, 2024 | stockhouse.comPulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA(TM) Percutaneous Electrode SystemMarch 8, 2024 | businesswire.comPulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode SystemFebruary 16, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Cross Below 50-Day Moving Average of $9.63Pulse Biosciences (NASDAQ:PLSE) Share Price Passes Below Fifty Day Moving Average of $9.63February 14, 2024 | markets.businessinsider.comPulse Biosciences Announces Positive Results For CellFX NsPFA 360 Cardiac Catheter Study; Stock UpFebruary 14, 2024 | finance.yahoo.comPulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyFebruary 14, 2024 | businesswire.comPulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyFebruary 8, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Share Price Passes Below Fifty Day Moving Average of $9.73Pulse Biosciences (NASDAQ:PLSE) Share Price Crosses Below Fifty Day Moving Average of $9.73February 2, 2024 | finance.yahoo.comCompanies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In GrowthJanuary 31, 2024 | finance.yahoo.comPulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF SymposiumJanuary 6, 2024 | finance.yahoo.comInsiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchasesJanuary 2, 2024 | finance.yahoo.comPulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac ClampDecember 20, 2023 | finance.yahoo.comPulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. PLSE Media Mentions By Week PLSE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLSE News Sentiment▼1.190.81▲Average Medical News Sentiment PLSE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLSE Articles This Week▼101▲PLSE Articles Average Week Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARAY News Today CTSO News Today NVCR News Today ICUI News Today IART News Today UFPT News Today LMAT News Today ATEC News Today MDXG News Today ATRC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLSE) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.